Metagenomic next-generation sequencing for diagnosis of immune checkpoint inhibitor-associated pneumonitis: a retrospective comparative clinical performance study

Key Points

• mNGS outperforms conventional methods in diagnostic accuracy and timeliness for identifying pneumonitis.
• The study involves comparing metagenomic sequencing and conventional methods among immunotherapy patients with pneumonia.
• Results demonstrate that incorporating mNGS could enhance the identification of the cause of pneumonitis and individualize treatment plans.
• Further large-scale prospective studies are needed to validate and expand upon these findings.

Abstract